VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 107 filers reported holding VAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,533,169 | +2.7% | 69,305 | +0.6% | 0.03% | -3.3% |
Q2 2023 | $3,439,817 | +74.1% | 68,879 | +30.6% | 0.03% | +76.5% |
Q1 2023 | $1,976,170 | -23.1% | 52,726 | -1.6% | 0.02% | -26.1% |
Q4 2022 | $2,570,456 | +230.4% | 53,607 | +65.4% | 0.02% | +228.6% |
Q3 2022 | $778,000 | +3.3% | 32,411 | -6.3% | 0.01% | 0.0% |
Q2 2022 | $753,000 | – | 34,595 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 4,168,718 | $100,049,000 | 34.21% |
Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $45,299,000 | 18.86% |
Pivotal bioVenture Partners Investment Advisor LLC | 776,039 | $18,625,000 | 6.81% |
Kynam Capital Management, LP | 698,638 | $16,767,000 | 3.53% |
GREAT POINT PARTNERS LLC | 600,000 | $14,400,000 | 3.47% |
Frazier Life Sciences Management, L.P. | 1,547,405 | $37,138,000 | 2.86% |
Ghost Tree Capital, LLC | 360,000 | $8,640,000 | 2.42% |
RA Capital Management | 4,581,203 | $109,949,000 | 2.35% |
Opaleye Management Inc. | 190,000 | $4,560,000 | 1.88% |
TPG GP A, LLC | 3,285,504 | $78,852,000 | 1.29% |